E-LIB Suche - Ergebnisse für: Chan, Phyllis

1

PP01.99 Switching to Subcutaneous (SC) Atezolizumab After I..:

Liu, Stephanie N. ; Chan, Phyllis ; Marchand, Mathilde...
Journal of Thoracic Oncology. 19 (2024) 7 - p. e44 , 2024

Link: https://doi.org/10.1016/..

2

Phase I pharmacokinetic, safety, and preliminary efficacy s..:

Shemesh, Colby S. ; Wang, Yongsheng ; An, Andrew...
Cancer Chemotherapy and Pharmacology. 94 (2024) 1 - p. 45-55 , 2024

Link: https://doi.org/10.1007/..

3

External validation of a tumor growth inhibition-overall su..:

Kassir, Nastya ; Chan, Phyllis ; Dang, Steve.
Cancer Chemotherapy and Pharmacology. 92 (2023) 3 - p. 205-210 , 2023

Link: https://doi.org/10.1007/..

4

Early Decision Making in a Randomized Phase II Trial of Ate..:

Shemesh, Colby S. ; Chan, Phyllis ; Marchand, Mathilde...
Clinical Pharmacology & Therapeutics. 114 (2023) 3 - p. 644-651 , 2023

Link: https://doi.org/10.1002/..

5

Comparison of two‐stage and joint TGI‐OS modeling using dat..:

Gonçalves, Antonio ; Marchand, Mathilde ; Chan, Phyllis...
CPT: Pharmacometrics & Systems Pharmacology. 13 (2023) 1 - p. 68-78 , 2023

Link: https://doi.org/10.1002/..

6

Development of a pediatric physiologically-based pharmacoki..:

Huang, Weize ; Stader, Felix ; Chan, Phyllis...
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

7

Applications of Model-Based Meta-Analysis in Drug Developme..:

Chan, Phyllis ; Peskov, Kirill ; Song, Xuyang
Pharmaceutical Research. 39 (2022) 8 - p. 1761-1777 , 2022

Link: https://doi.org/10.1007/..

8

Tumor Growth Inhibition-Overall Survival (TGI-OS) Model for..:

Yoshida, Kenta ; Chan, Phyllis ; Marchand, Mathilde...
The AAPS Journal. 24 (2022) 3 - p. , 2022

Link: https://doi.org/10.1208/..

9

Extension of the Alternative Intravenous Dosing Regimens of..:

Liu, Stephanie N. ; Marchand, Mathilde ; Liu, Xiaoyan...
The Journal of Clinical Pharmacology. 62 (2022) 11 - p. 1393-1402 , 2022

Link: https://doi.org/10.1002/..

10

C-Terminal Lysine Processing of IgG in Human Suction Bliste..:

Ayalew, Luladey ; Chan, Phyllis ; Hu, Zhilan...
Molecular Pharmaceutics. 19 (2022) 11 - p. 4043-4054 , 2022

Link: https://doi.org/10.1021/..

11

Update to improve reproducibility and interpretability: A r..:

Chan, Phyllis ; Lu, James ; Bruno, René.
CPT: Pharmacometrics & Systems Pharmacology. 11 (2022) 3 - p. 262-263 , 2022

Link: https://doi.org/10.1002/..

12

Time-dependent population PK models of single-agent atezoli..:

Marchand, Mathilde ; Zhang, Rong ; Chan, Phyllis...
Cancer Chemotherapy and Pharmacology. 88 (2021) 2 - p. 211-221 , 2021

Link: https://doi.org/10.1007/..

13

Translational and pharmacokinetic‐pharmacodynamic applicati..:

Chan, Phyllis ; Ding, Han Ting ; Liederer, Bianca M....
Clinical and Translational Science. 14 (2021) 5 - p. 1945-1954 , 2021

Link: https://doi.org/10.1111/..

14

Evaluation of atezolizumab immunogenicity: Clinical pharmac..:

Wu, Benjamin ; Sternheim, Nitzan ; Agarwal, Priya...
Clinical and Translational Science. 15 (2021) 1 - p. 130-140 , 2021

Link: https://doi.org/10.1111/..

15

Prediction of overall survival in patients across solid tum..:

Chan, Phyllis ; Marchand, Mathilde ; Yoshida, Kenta...
CPT: Pharmacometrics & Systems Pharmacology. 10 (2021) 10 - p. 1171-1182 , 2021

Link: https://doi.org/10.1002/..